Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Rosse

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
ACS Medicinal Chemistry Letters|January 29, 2016
Pyrrolidinones as Modulators of NeurogenesisGerard Rosse
ACS Medicinal Chemistry Letters|November 20, 2024
Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer's Disease and Parkinson's DiseaseGerard Rosse
ACS Medicinal Chemistry Letters|February 21, 2019
Novel Bis-heteroaryl Derivatives To Modulate Protein Aggregation for the Treatment of Neurodegenerative DiseasesGerard Rosse
ACS Medicinal Chemistry Letters|December 20, 2023
Phenyl-quinoline-xxo-butyric Acid Inhibitors of Histone Lysine Demethylase for the Treatment of CancerGerard Rosse
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Aminopyrazole Inhibitors of PDE11A for the Treatment of Alzheimer's Disease and Other Types of DementiaGerard Rosse
ACS Medicinal Chemistry Letters|January 16, 2015
Quinalozinones as Inhibitors of Class I PI3K KinasesGerard Rosse
ACS Medicinal Chemistry Letters|January 16, 2015
Novel azaindazole sulfonamides inhibitors of serum and glucocorticoid regulated kinaseGerard Rosse
ACS Medicinal Chemistry Letters|December 21, 2016
Macrocyclic Inhibitors of ERK2 KinaseGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Preparation of Novel Pyrazolyl Guanidine as F1F0-ATPase Inhibitors: Patent HighlightGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Pharmaceutical composition comprising indole compound for treatment of diseases associated with oxidative stress: patent highlightGerard Rosse
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
ACS Medicinal Chemistry Letters|January 29, 2016
Pyrrolidinones as Modulators of NeurogenesisGerard Rosse
ACS Medicinal Chemistry Letters|November 20, 2024
Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer's Disease and Parkinson's DiseaseGerard Rosse
ACS Medicinal Chemistry Letters|February 21, 2019
Novel Bis-heteroaryl Derivatives To Modulate Protein Aggregation for the Treatment of Neurodegenerative DiseasesGerard Rosse
ACS Medicinal Chemistry Letters|December 20, 2023
Phenyl-quinoline-xxo-butyric Acid Inhibitors of Histone Lysine Demethylase for the Treatment of CancerGerard Rosse
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Aminopyrazole Inhibitors of PDE11A for the Treatment of Alzheimer's Disease and Other Types of DementiaGerard Rosse
ACS Medicinal Chemistry Letters|January 16, 2015
Quinalozinones as Inhibitors of Class I PI3K KinasesGerard Rosse
ACS Medicinal Chemistry Letters|January 16, 2015
Novel azaindazole sulfonamides inhibitors of serum and glucocorticoid regulated kinaseGerard Rosse
ACS Medicinal Chemistry Letters|December 21, 2016
Macrocyclic Inhibitors of ERK2 KinaseGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Preparation of Novel Pyrazolyl Guanidine as F1F0-ATPase Inhibitors: Patent HighlightGerard Rosse
ACS Medicinal Chemistry Letters|June 6, 2014
Pharmaceutical composition comprising indole compound for treatment of diseases associated with oxidative stress: patent highlightGerard Rosse
Pageof 9